Tag Archive for: Dr Reddy’s

Indian pharma companies have started developing their own versions of Novo Nordisk’s top-selling weight-loss medicine Wegovy (semaglutide), hoping for a piece of the multibillion-dollar obesity market.

The global pharma company also secured ‘Gold Medal’ status from global sustainability ratings agency, EcoVadis.

Rivals Sun Pharma’s Dadra facility and Torrent Pharmaceuticals Ltd’s oncology unit are also undergoing FDA inspections, according to reports.

Eton Pharmaceuticals, Inc has sold its hospital products to Dr. Reddy’s Laboratories SA, a subsidiary of Dr. Reddy’s Laboratories, Ltd. for total payments of up to $50 million.